Original Article
Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study
Reducción de la actividad de la enfermedad, el uso de corticosteroides y recursos sanitarios en pacientes con lupus eritematoso sistémico tratados con belimumab en práctica clínica real: estudio multicéntrico OBSErve España
Josefina Cortés-Hernándeza,
, Carlos Marras Fernández-Cidb, Jose Luis Andreu Sánchezc, Jaime Calvo Alénd, Angel M. García-Aparicioe, Elvira Díez Álvarezf, Francisco Javier Hidalgo Bermejog,1, Carlos Coronellh, Alessandra Pernai,1, Josep Ordi Rosa
Corresponding author
a Rheumatology Department, Hospital Vall d’Hebron, Barcelona, Spain
b Rheumatology Department, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain
c Rheumatology Department, Hospital Universitario Puerta de Hierro-Majadahonda, Madrid, Spain
d Rheumatology Department, Hospital Universitario de Araba, Vitoria, Spain
e Rheumatology Department, Hospital Universitario de Toledo, Toledo, Spain
f Rheumatology Department, Hospital Universitario de León, León, Spain
g Medical Department, GSK, Madrid, Spain
h Primary Care Medical Center of Vallirana, Barcelona, Spain, formerly Medical Department, GSK, Madrid, Spain
i Specialty Franchise, GSK, London, UK
Ver másRead
571
Timeswas read the article
181
Total PDF
390
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 May | 20 | 9 | 29 |
| 2024 April | 97 | 33 | 130 |
| 2024 March | 57 | 35 | 92 |
| 2024 February | 56 | 38 | 94 |
| 2024 January | 97 | 35 | 132 |
| 2023 December | 61 | 28 | 89 |
| 2023 November | 1 | 3 | 4 |
| 2023 July | 1 | 0 | 1 |
